MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting

Reuters

昨天

MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting

MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537955718"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537955718\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537955718?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 03:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537955718","market":"us","top_or_hot":-1,"title":"MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-22 03:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4112","symbol_name":"金融交易所和數據","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL4YYWcs:1","article_id":"2537955718","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537955718","pubTimestamp":1747854915,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"MediPharm Labs Corp. , a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely infor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4112":"金融交易所和数据","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4588":"碎股","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","NDAQ":"纳斯达克OMX交易所"},"translate_title":"MediPharm Labs Corp.敦促股东通过绿色代理投票，在6月16日会议之前支持公司的提名人","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9},"content_text":"MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    \n\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}